Anna C Seale1, Christina W Obiero, James A Berkley. 1. aDepartment of Infectious Diseases Informatics, UCL Institute for Health Informatics, Farr Institute, University College London bImperial NHS Trust, London, UK cKEMRI/Wellcome Trust Research Programme, Kilifi, Kenya dThe Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK.
Abstract
PURPOSE OF REVIEW: This review discusses the rational development of guidelines for the management of neonatal sepsis in developing countries. RECENT FINDINGS: Diagnosis of neonatal sepsis with high specificity remains challenging in developing countries. Aetiology data, particularly from rural, community-based studies, are very limited, but molecular tests to improve diagnostics are being tested in a community-based study in South Asia. Antibiotic susceptibility data are limited, but suggest reducing susceptibility to first-and second-line antibiotics in both hospital and community-acquired neonatal sepsis. Results of clinical trials in South Asia and sub-Saharan Africa assessing feasibility of simplified antibiotic regimens are awaited. SUMMARY: Effective management of neonatal sepsis in developing countries is essential to reduce neonatal mortality and morbidity. Simplified antibiotic regimens are currently being examined in clinical trials, but reduced antimicrobial susceptibility threatens current empiric treatment strategies. Improved clinical and microbiological surveillance is essential, to inform current practice, treatment guidelines, and monitor implementation of policy changes.
PURPOSE OF REVIEW: This review discusses the rational development of guidelines for the management of neonatal sepsis in developing countries. RECENT FINDINGS: Diagnosis of neonatal sepsis with high specificity remains challenging in developing countries. Aetiology data, particularly from rural, community-based studies, are very limited, but molecular tests to improve diagnostics are being tested in a community-based study in South Asia. Antibiotic susceptibility data are limited, but suggest reducing susceptibility to first-and second-line antibiotics in both hospital and community-acquired neonatal sepsis. Results of clinical trials in South Asia and sub-Saharan Africa assessing feasibility of simplified antibiotic regimens are awaited. SUMMARY: Effective management of neonatal sepsis in developing countries is essential to reduce neonatal mortality and morbidity. Simplified antibiotic regimens are currently being examined in clinical trials, but reduced antimicrobial susceptibility threatens current empiric treatment strategies. Improved clinical and microbiological surveillance is essential, to inform current practice, treatment guidelines, and monitor implementation of policy changes.
Authors: Barbara J Stoll; Nellie I Hansen; Pablo J Sánchez; Roger G Faix; Brenda B Poindexter; Krisa P Van Meurs; Matthew J Bizzarro; Ronald N Goldberg; Ivan D Frantz; Ellen C Hale; Seetha Shankaran; Kathleen Kennedy; Waldemar A Carlo; Kristi L Watterberg; Edward F Bell; Michele C Walsh; Kurt Schibler; Abbot R Laptook; Andi L Shane; Stephanie J Schrag; Abhik Das; Rosemary D Higgins Journal: Pediatrics Date: 2011-04-25 Impact factor: 7.124
Authors: Kondwani Kawaza; Heather E Machen; Jocelyn Brown; Zondiwe Mwanza; Suzanne Iniguez; Al Gest; E O'Brian Smith; Maria Oden; Rebecca R Richards-Kortum; Elizabeth Molyneux Journal: PLoS One Date: 2014-01-29 Impact factor: 3.240
Authors: Anna C Seale; Hannah Blencowe; Anita Zaidi; Hammad Ganatra; Sana Syed; Cyril Engmann; Charles R Newton; Stefania Vergnano; Barbara J Stoll; Simon N Cousens; Joy E Lawn Journal: Pediatr Res Date: 2013-12 Impact factor: 3.756
Authors: Michael Sgro; Anna Kobylianskii; Mark H Yudin; Dat Tran; Julia Diamandakos; Jonathan Sgro; Douglas M Campbell Journal: Paediatr Child Health Date: 2018-04-24 Impact factor: 2.253
Authors: N A Mobbs; J Ditai; J Abeso; E B Faragher; E D Carrol; M Gladstone; A Medina-Lara; P Olupot-Olupot; A D Weeks Journal: Pilot Feasibility Stud Date: 2019-03-13